C

Calcutta School Of Tropical Medicine | Department of Clinical and Experimental Pharmacology

Research site
(Unclaimed)
Location
108, Chittaranjan Avenue, Kolkata, West Bengal, India
Site insights

Top conditions

Dermatitis (2 trials)

Atopic Dermatitis (2 trials)

Eczema (2 trials)

Pneumococcal Infections (1 trial)

COVID-19 (1 trial)

Top treatments

ASLAN004
Abrocitinib
S-217622

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)

The main aim of this study is to evaluate the efficacy of S-217622 versus placebo among outpatient adults with mild and moderate COVID-19 starting in...

Active, not recruiting
SARS-CoV-2 Infection
Drug: S-217622
Drug: Placebo

The purpose of this clinical trial is to learn about the safety and how well the study medicine (called Abrocitinib) works for the potential treatmen...

Active, not recruiting
Atopic Dermatitis
Drug: Abrocitinib 100 mg
Drug: Abrocitinib 200 mg

Trial sponsors

Pfizer logo

Pfizer (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems